EN DE
Watch Genetec Technology Bhd for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Genetec Technology Bhd (0104) fair value: what the stock is really worth

As of Nov 18, 2026: fair value (intrinsic value) of Genetec Technology Bhd stock MYR 0.23, price MYR 0.29, that is 19.3% below the price, quality 29 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials MY · ISIN MYQ0104OO008

GT Genetec Technology Bhd logo Thin data Nov 16, 2026

Genetec Technology Bhd

0104 · KLSE

Expensive (fair value 19% below the price), weak company and price moving sideways: meets none of the 3 rules.

Follow free in the weekly email
Low debt 
Price moving sideways (no uptrend) 
Revenue last quarter 50% below a year ago. 
Fair value 0.2340 MYR · Overvalued 
Quality 29/100 
Weak Growth (revenue 3y −24.8 %/yr in MYR) 
Loss-making · -140.9% net margin (TTM) 
Negative free cash flow 
Trails peers (4/11) 
Narrow moat 6/100 · thin data
Thin data 
Estimate
Watch Genetec Technology Bhd for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

3.73 MYR 0.1550 MYR Fair Value 0.2340 MYR Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range 0.1550 MYR – 3.73 MYR · fair‑value band 0.1755 MYR – 0.2925 MYR · the 0.2900 MYR price screens above the 0.2340 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Genetec Technology Bhd in your weekly email

Every Wednesday you see whether Genetec Technology Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Genetec Technology Berhad, an investment holding company, designs, manufactures, and sells smart automation systems, customized factory automated equipment, and integrated systems in the United States, Europe, the Middle East, Malaysia, Thailand, Mexico, and internationally.

Show moreShow less

The company offers assembly solutions, including robotic pick and place, auto fastening, screw driving, dosing, plasma treatment, plastic and metal laser welding, laser marking, servo press, high precision cam driven, and buffer system products; material handling products, such as cartesian robot pick and place integration, robotic integration, auto feed system, and linear feeding system products; and testing and inspection products comprising vision inspection, functional and pressure tests, laser distance measurement, and test integration products.

It also provides in-house machining centers; precision tooling jigs and fixtures; aluminium profiles; and engineering services, as well as conceptual design, prototype development, and equipment mass replication.

The company serves electric vehicle and battery, automotive, computer peripherals, consumer goods, and healthcare industries. The company was incorporated in 1997 and is headquartered in Bandar Baru Bangi, Malaysia.

Stock analysis

Genetec Technology Bhd (0104) currently trades at 0.2900 MYR, while our estimate is 0.2340 MYR, 19% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: 0.1755 MYR (bear) to 0.2925 MYR (bull), the price of 0.2900 MYR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 29/100 (below-average quality), in the Industrials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Genetec Technology Bhd reported revenue of 125M MYR in FY2026 versus 224M MYR in FY2022, a compound −13.5%/yr. Reported net income was −175M MYR in FY2026.

Key figures

Market cap 225M MYR (≈ $54.6M) Micro · P/S ratio 2.10 · EPS (TTM) −0.1900 MYR · Dividend yield 7.3% · Net margin −141% · Return on equity −40.1% · Return on assets (EBIT) 3.1% (5-year average) · Operating margin −68.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

The share trades about 32% below its 52-week high and 87% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −46% fair-value upside, at −19%, 0104 screens cheaper than that median.

Fair Value

Bear 0.1755 MYR Fair Value 0.2340 MYR Bull 0.2925 MYR
Price 0.2900 MYR · Downside -19.3%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 29/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 2
How much profit the company makes from its sales and capital
Quality Growth 0
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 55
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 29
How calm the share price moves, does not count
Price momentum 31
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 40
Distance to the 52-week high, does not count
New shares 74
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 11/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−43.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−24.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.2%
Start year 2021 (pandemic). Over 10 years: −0.3% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.6% (2021) → −103.9% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

0104 screens overvalued: fair value 19% below the price. Compare with SIE →

Compare Genetec Technology Bhd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 854 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 29 · Bottom 25%
Fair Value upside −19.3% · Above median
Profitability
Return on assets −39.6% · Bottom 25%
Net margin (12 months) −140.9% · Bottom 25%
Operating margin (12 months) −68.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −50.3% · Bottom 25%
Dividend yield (12 months) 7.3% · Top 25%

Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper

P/B 0.74× · Cheapest 25%
P/S (12 months) 2.19× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)8 · sector 1
FUTURE (revenue growth)0 · sector 32
PAST (return on equity)0 · sector 27
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)100 · sector 28

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Cummins Inc CMI $433.97 $359.36 −17% vs 0104
SIE SIE €266.00 €192.09 −28% vs 0104
Sandvik AB SAND kr 333.90 kr 194.33 −42% vs 0104
Illinois Tool Works Inc ITW $281.67 $154.30 −45% vs 0104
AMETEK, Inc AME $234.84 $125.74 −46% vs 0104
Parker-Hannifin Corporation PH $920.84 $492.92 −46% vs 0104
Emerson Electric Co EMR $159.15 $79.99 −50% vs 0104
Rockwell Automation, Inc ROK $391.26 $186.75 −52% vs 0104
Eaton Corporation ETN $337.11 $156.90 −53% vs 0104
GE Vernova Inc GEV $779.91 $211.78 −73% vs 0104

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Genetec Technology Bhd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Genetec Technology Bhd Fair Value". https://www.fairvalue-calculator.com/stock/0104

Frequently asked questions

Is Genetec Technology Bhd (0104) overvalued or undervalued?
As of Nov 16, 2026, our estimate of fair value is 0.2340 MYR versus a price of 0.2900 MYR, about 19% lower (overvalued).
What is the fair value of 0104?
Our estimate for Genetec Technology Bhd is 0.2340 MYR (as of Nov 16, 2026), built from audited fundamentals. The current price: 0.2900 MYR.
What is the quality score of 0104?
Genetec Technology Bhd has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Genetec Technology Bhd (0104)?
Our calculated price target is the estimate of 0.2340 MYR (as of Nov 16, 2026). Cautious scenario 0.1755 MYR, optimistic scenario 0.2925 MYR. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Genetec Technology Bhd stock forecast for 2026?
Our estimate puts fair value at 0.2340 MYR, about 19% lower versus a price of 0.2900 MYR (overvalued). Cautious scenario 0.1755 MYR, optimistic scenario 0.2925 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Genetec Technology Bhd (0104)?
Genetec Technology Bhd reported trailing-twelve-month revenue of about 103M MYR (latest available figure, as of Nov 16, 2026).
Does Genetec Technology Bhd pay a dividend?
Genetec Technology Bhd currently shows a dividend yield of 7.25% relative to its recent price (as of Nov 16, 2026).
How much is the dividend of Genetec Technology Bhd (0104)?
Genetec Technology Bhd has a dividend yield of 7.3%.
What is the intrinsic value of Genetec Technology Bhd (0104)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Genetec Technology Bhd it is 0.2340 MYR per share (as of Nov 16, 2026), against a price of 0.2900 MYR.
Is Genetec Technology Bhd stock overvalued or undervalued in 2026?
As of Nov 16, 2026, 0104 trades above its calculated fair value: price 0.2900 MYR, fair value 0.2340 MYR, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0104?
No. The price is what the market pays today (0.2900 MYR); the fair value is what the company's own numbers justify (0.2340 MYR). For Genetec Technology Bhd the two are 0.0560 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Genetec Technology Bhd worth?
The market values Genetec Technology Bhd at about 225M MYR (market capitalisation, as of Nov 16, 2026). Per share that is 0.2900 MYR; our models calculate a fair value of 0.2340 MYR per share.
What do the bullish and bearish scenarios say about 0104?
Our models span a range for Genetec Technology Bhd: cautious scenario 0.1755 MYR, base 0.2340 MYR, optimistic 0.2925 MYR per share (as of Nov 16, 2026, price 0.2900 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Genetec Technology Bhd (0104)?
Balance-sheet figures for Genetec Technology Bhd (as of Nov 16, 2026): return on equity −40.1%. They feed the Quality Score of 29/100, which measures business quality independently of the share price.
How far is 0104 from its 52-week high?
Genetec Technology Bhd trades at 0.2900 MYR, about 32% below its 52-week high of 0.4250 MYR and 87% above the low of 0.1550 MYR (as of Nov 18, 2026). Distance from the high says nothing about value: that is what the fair value of 0.2340 MYR is for.
Which stocks are comparable to Genetec Technology Bhd?
From the same area (Industrials) we also value SIE, GE Vernova Inc, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Genetec Technology Bhd stock attractive at the current price?
The data as of Nov 16, 2026: price 0.2900 MYR, calculated fair value 0.2340 MYR (−19%), Quality Score 29/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3% above its aggregate fair value. Genetec Technology Bhd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Genetec Technology Bhd (0104)?
The closing price on Nov 18, 2026 was 0.2900 MYR. Our estimate is 0.2340 MYR, about 19% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Genetec Technology Bhd right now?
Weak quality (29/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Genetec Technology Bhd

How large is the market capitalisation of Genetec Technology Bhd (0104)?
The market capitalisation of Genetec Technology Bhd is 225M MYR (≈ $54.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Genetec Technology Bhd (0104)?
The price-to-sales ratio of Genetec Technology Bhd is 2.10 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Genetec Technology Bhd (0104)?
Earnings per share at Genetec Technology Bhd are −0.1900 MYR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Genetec Technology Bhd (0104)?
The dividend yield of Genetec Technology Bhd is 7.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Genetec Technology Bhd (0104)?
The net margin of Genetec Technology Bhd is −141% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Genetec Technology Bhd (0104)?
The return on equity (ROE) of Genetec Technology Bhd is −40.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Genetec Technology Bhd (0104)?
On an EBIT basis the return on assets of Genetec Technology Bhd is 3.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Genetec Technology Bhd (0104)?
The operating margin of Genetec Technology Bhd is −68.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Genetec Technology Bhd (0104)?
Revenue at Genetec Technology Bhd is down 50.3% versus a year earlier (3y avg −24.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Genetec Technology Bhd (0104)?
Earnings per share at Genetec Technology Bhd are growing 53.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Genetec Technology Bhd (0104) generate?
The free cash flow of Genetec Technology Bhd is −113M MYR (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Genetec Technology Bhd (0104) carry?
The net debt of Genetec Technology Bhd is 58.1M MYR (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Genetec Technology Bhd in the live analysis

One click puts Genetec Technology Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.